STAT3 and neoplasm: Meanwhile, SMARCB1 deletion led to the upregulation of the IL6/JAK/STAT3 signaling pathway, which activated the transcriptional activity of STAT3 and enhanced the proliferative and invasive abilities of tumor cells.